Trial Profile
An open-label, randomized, 3-way crossover study to assess the effect of Colesevelam HCl (WelcholA) 3750 mg on the single dose pharmacokinetics of Glipizide ER 20 mg in healthy human adult subjects
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 19 Nov 2018
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; Glipizide
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 13 Feb 2010 New trial record